News & Articles
Selected Filters:
Using CRISPR as a research tool to develop cancer treatments
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
An on-off switch for gene editing
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
Single dose of Pfizer-BioNTech or Oxford-AstraZenca vaccine reduces infection rate by 65%, study finds
COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
Oxford University and Prenetics announce landmark collaboration to scale rapid testing tech globally
A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics
Abbott's Panbio Rapid Antigen Test gains CE Mark for use on children
First rapid antigen test with performance data on children
PsychLight sensor to enable discovery of new psychiatric drugs
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
Novel "hydrogel" carriers for anti-cancer drugs offer new hope for cancer treatment
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
Cancer immunotherapies: How single-cell sequencing can aid informed decision-making
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
DNA Script has partnered with Moderna to develop on-demand vaccines and therapeutics for DARPA
The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic
A year on from launch, north-west Lighthouse Lab celebrates 10 million sample milestone
The MDC Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s COVID-19 testing rollout, has announced it has processed its 10 millionth test
Keeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
Avacta receives clinical validation of AffiDX SARS-CoV-2 antigen lateral flow test
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
Abbott’s new coronary imaging platform powered by artificial intelligence has launched in Europe
The Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment
LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
Artificial Intelligence could create better outcomes for bowel cancer patients
AI could hold the key to more targeted treatment, according to new research